Catabasis Pharmaceuticals Inc., of Cambridge, Mass., set terms for its IPO. The company plans to raise approximately $60 million by offering 4.3 million shares priced in a range of $13 to $15 and said certain principal stockholders indicated interest in purchasing up to approximately $18 million in shares at the IPO price.